FindTrial
Sign In

Study on half-effective volume of 0.25% ropivacaine for distal adductor canal block

Study on half-effective volume of 0.25% ropivacaine for distal adductor canal block

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067321
Enrollment
Unknown
Registered
2023-01-04
Start date
2023-01-14
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee joint injury

Interventions

Group 1:Distal Adductor canal block
Group 2:Intra-articular analgesia with local anesthetics and distal adductor block were used

Sponsors

The Second Hospital, Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years old; 2. BMI 18-30 kg/m2; 3. ASA I-II level; 4. No serious visual or hearing impairment.

Exclusion criteria

Exclusion criteria: 1. History of allergic reaction to narcotic drugs; 2. Abnormal platelet or coagulation function; 3. Scar and infection at puncture site; 4. Long-term drinking, chronic pain or long-term use of psychotropic drugs; 5. Severe heart, lung, liver and renal dysfunction; 6. Neuromuscular lesion of lower limbs; 7. Those who have a history of epilepsy, nervous system diseases or complicated with craniocerebral injury and cannot communicate normally.

Design outcomes

Primary

MeasureTime frame
visual analogue scale;—

Secondary

MeasureTime frame
Total morphine-equivalent consumption;The earliest time of ambulation;block level;—

Countries

China

Contacts

Public ContactXin Zhao

The Second Hospital, Shandong University

lujnzx@sohu.com+86 176 6008 5551

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026